US 9611230
1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted A61PA61P1/16A61P11/00
Quick answer
US patent 9611230 (1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P19/00